Literature DB >> 28268252

The association between metabolic health, obesity phenotype and the risk of breast cancer.

Yong-Moon Mark Park1, Alexandra J White1, Hazel B Nichols2, Katie M O'Brien3, Clarice R Weinberg3, Dale P Sandler1.   

Abstract

Beyond the current emphasis on body mass index (BMI), it is unknown whether breast cancer risk differs between metabolically healthy and unhealthy normal weight or overweight/obese women. The Sister Study is a nationwide prospective cohort study. Data came from 50,884 cohort participants aged 35 to 74 years enrolled from 2003 through 2009. Cox proportional hazards models were used to estimate multivariable adjusted hazard ratios (HR) and 95% confidence intervals (CIs) for breast cancer risk. Metabolic abnormalities considered included: high waist circumference (≥88 cm); elevated blood pressure (≥130/85 mm Hg or antihypertensive medication); previously diagnosed diabetes or antidiabetic drug treatment; and cholesterol-lowering medication use. During follow-up (mean, 6.4 years), 1,388 invasive breast cancers were diagnosed at least 1 year after enrollment. Compared to women with BMI <25 kg/m2 with no metabolic abnormalities (metabolically healthy normal weight phenotype), women with a BMI <25 kg/m2 and ≥1 metabolic abnormality (metabolically unhealthy, normal weight phenotype) had increased risk of postmenopausal breast cancer (HR = 1.26, 95% CI: 1.01-1.56), as did women with a BMI ≥25 kg/m2 and no metabolic abnormalities (metabolically healthy overweight/obese phenotype) (HR = 1.24, 95% CI: 0.99-1.55). Furthermore, risk of postmenopausal breast cancer was consistently elevated in women with normal BMI and central obesity (normal weight central obesity phenotype) regardless of the criterion used to define central obesity, with HR for waist circumference ≥88 cm, waist circumference ≥80 cm, and waist-hip ratio ≥0.85 of 1.58, 95% CI: 1.02-2.46; 1.38, 95% CI: 1.09-1.75; and 1.38, 95% CI: 1.02-1.85, respectively. There was an inverse association between premenopausal breast cancer and metabolically healthy overweight/obese phenotype (HR = 0.71, 95% CI: 0.52-0.97). Our findings suggest that postmenopausal women who are metabolically unhealthy or have central adiposity may be at increased risk for breast cancer despite normal BMI.
© 2017 UICC.

Entities:  

Keywords:  metabolic health; metabolically healthy obese; metabolically unhealthy normal weight; normal weight central obesity; obesity; postmenopausal breast cancer

Mesh:

Year:  2017        PMID: 28268252      PMCID: PMC5406245          DOI: 10.1002/ijc.30684

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  51 in total

1.  Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.

Authors:  Jean A McDougall; Kathleen E Malone; Janet R Daling; Kara L Cushing-Haugen; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-05       Impact factor: 4.254

2.  Risk-benefit profiles of women using tamoxifen for chemoprevention.

Authors:  Hazel B Nichols; Lisa A DeRoo; Daniel R Scharf; Dale P Sandler
Journal:  J Natl Cancer Inst       Date:  2014-12-03       Impact factor: 13.506

3.  Mediterranean diet, Dietary Approaches to Stop Hypertension (DASH) style diet, and metabolic health in U.S. adults.

Authors:  Yong-Moon Mark Park; Susan E Steck; Teresa T Fung; Jiajia Zhang; Linda J Hazlett; Kyungdo Han; Seung-Hwan Lee; Hyuk-Sang Kwon; Anwar T Merchant
Journal:  Clin Nutr       Date:  2016-09-08       Impact factor: 7.324

Review 4.  Obesity, adipocytokines, and insulin resistance in breast cancer.

Authors:  D P Rose; D Komninou; G D Stephenson
Journal:  Obes Rev       Date:  2004-08       Impact factor: 9.213

5.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality.

Authors:  Abel Romero-Corral; Virend K Somers; Justo Sierra-Johnson; Yoel Korenfeld; Simona Boarin; Josef Korinek; Michael D Jensen; Gianfranco Parati; Francisco Lopez-Jimenez
Journal:  Eur Heart J       Date:  2009-11-20       Impact factor: 29.983

6.  Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype.

Authors:  Patrick T Bradshaw; June Stevens
Journal:  Am J Epidemiol       Date:  2015-09-12       Impact factor: 4.897

7.  A prospective study of occupational physical activity and breast cancer risk.

Authors:  Christine C Ekenga; Christine G Parks; Dale P Sandler
Journal:  Cancer Causes Control       Date:  2015-10-08       Impact factor: 2.506

8.  The natural course of healthy obesity over 20 years.

Authors:  Joshua A Bell; Mark Hamer; Séverine Sabia; Archana Singh-Manoux; G David Batty; Mika Kivimaki
Journal:  J Am Coll Cardiol       Date:  2015-01-06       Impact factor: 24.094

Review 9.  Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress.

Authors:  Patrizia Ferroni; Silvia Riondino; Oreste Buonomo; Raffaele Palmirotta; Fiorella Guadagni; Mario Roselli
Journal:  Oxid Med Cell Longev       Date:  2015-06-11       Impact factor: 6.543

10.  Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change.

Authors:  Peter Würtz; Qin Wang; Antti J Kangas; Rebecca C Richmond; Joni Skarp; Mika Tiainen; Tuulia Tynkkynen; Pasi Soininen; Aki S Havulinna; Marika Kaakinen; Jorma S Viikari; Markku J Savolainen; Mika Kähönen; Terho Lehtimäki; Satu Männistö; Stefan Blankenberg; Tanja Zeller; Jaana Laitinen; Anneli Pouta; Pekka Mäntyselkä; Mauno Vanhala; Paul Elliott; Kirsi H Pietiläinen; Samuli Ripatti; Veikko Salomaa; Olli T Raitakari; Marjo-Riitta Järvelin; George Davey Smith; Mika Ala-Korpela
Journal:  PLoS Med       Date:  2014-12-09       Impact factor: 11.069

View more
  38 in total

1.  Dietary inflammatory potential and risk of mortality in metabolically healthy and unhealthy phenotypes among overweight and obese adults.

Authors:  Yong-Moon Mark Park; Moon Kyung Choi; Seong-Su Lee; Nitin Shivappa; Kyungdo Han; Susan E Steck; James R Hébert; Anwar T Merchant; Dale P Sandler
Journal:  Clin Nutr       Date:  2018-04-16       Impact factor: 7.324

2.  Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.

Authors:  Neil M Iyengar; Rhonda Arthur; JoAnn E Manson; Rowan T Chlebowski; Candyce H Kroenke; Lindsay Peterson; Ting-Yuan D Cheng; Elizabeth C Feliciano; Dorothy Lane; Juhua Luo; Rami Nassir; Kathy Pan; Sylvia Wassertheil-Smoller; Victor Kamensky; Thomas E Rohan; Andrew J Dannenberg
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

3.  Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.

Authors:  Geoffrey C Kabat; Mimi Y Kim; Jennifer S Lee; Gloria Y Ho; Scott B Going; Jennifer Beebe-Dimmer; JoAnn E Manson; Rowan T Chlebowski; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-09-22       Impact factor: 4.254

4.  Lipid Intake and Breast Cancer Risk: Is There a Link? A New Focus and Meta-Analysis.

Authors:  Massimo Lodi; Amélie Kiehl; Fei Lin Qu; Victor Gabriele; Catherine Tomasetto; Carole Mathelin
Journal:  Eur J Breast Health       Date:  2022-04-01

Review 5.  Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome.

Authors:  Sheetal Hardikar; Mary C Playdon; Prasoona Karra; Maci Winn; Svenja Pauleck; Alicja Bulsiewicz-Jacobsen; Lacie Peterson; Adriana Coletta; Jennifer Doherty; Cornelia M Ulrich; Scott A Summers; Marc Gunter
Journal:  Obesity (Silver Spring)       Date:  2022-07       Impact factor: 9.298

6.  The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Ping Zhao; Ning Xia; Hong Zhang; Tingting Deng
Journal:  Obes Facts       Date:  2020-07-22       Impact factor: 3.942

Review 7.  Preclinical Models to Study Obesity and Breast Cancer in Females: Considerations, Caveats, and Tools.

Authors:  Erin D Giles; Elizabeth A Wellberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-11-04       Impact factor: 2.673

8.  A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.

Authors:  Y-M M Park; D B Bookwalter; K M O'Brien; C L Jackson; C R Weinberg; D P Sandler
Journal:  Ann Oncol       Date:  2021-01-29       Impact factor: 32.976

9.  Diabetes and kidney cancer risk among post-menopausal women: The Iowa women's health study.

Authors:  Shuo Wang; Mark D Lo Galbo; Cindy Blair; Bharat Thyagarajan; Kristin E Anderson; DeAnn Lazovich; Anna Prizment
Journal:  Maturitas       Date:  2020-08-11       Impact factor: 4.342

Review 10.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.